Brief: Xintela Gets Notice Of Allowance From USPTO For Treatment Of Brain Tumors

Xintela AB

07/01/2021 07:33

Jan 7 (Reuters) - Xintela AB  XINT.ST :
    * XINTELA RECEIVES NOTICE OF ALLOWANCE FROM USPTO FOR THE
TREATMENT OF BRAIN TUMORS
    * US PATENT AND TRADEMARK OFFICE (USPTO) HAS ISSUED A NOTICE
OF
ALLOWANCE FOR COMPANY'S PATENT APPLICATION COVERING TARGETED
ANTIBODY TREATMENT OF TUMORS OF CENTRAL NERVOUS SYSTEM (CNS).
    * ONCE GRANTED, PATENT CAN BE KEPT IN FORCE UNTIL 2036

Source text for Eikon:  ID:nBQNxpNXL 
Further company coverage:  XINT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))